EUVIMEDEUVIMED entdecken
Crossref

Xia Ku Cao Paste restores intestinal microbiota homeostasis and improves hepatic metabolism disturbances to alleviate hyperlipidemia

Zhonghua Du, Xiaole Wang, Lei Xu, Zhimei Hu, Miaojing Liu, Xiaojuan Min, Junjie Hu, Yan Meng, Lichun Ye, Songlin Liu, Zhaohua Shi

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Zhonghua Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Gastrointestinal Microbiome, Drugs, Chinese Herbal, Liver. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hyperlipidemia (HLP) is one of the most critical pathogenic factors of cardiovascular disease. Xia Ku Cao Paste (XKCP) is a traditional Chinese medicine preparation primarily made from Prunella vulgaris L. Research on its therapeutic effects and mechanisms in treating HLP is currently limited. PURPOSE: The study aimed to investigate the efficacy, material basis, and potential mechanism of XKCP against HLP through in vitro and in vivo models. METHODS: In this study, the chemical constituents of XKCP and its blood-entry components were characterized using UPLC-Q-TOF-MS/MS. A high-fat diet (HFD)-induced HLP rats and sodium oleate (SO)-induced HepG2 cells served as the in vivo and in vitro models, respectively. Serum biochemistry, histopathological analysis, liver proteomics, gut microbiota analysis, short-chain fatty acids (SCFAs), free fatty acids (FFA) quantification, SCAP/SREBP-2 pathway-specific inhibitor interference and molecular docking were employed to evaluate therapeutic efficacy, elucidate the potential active components and pathways of XKCP against HLP. RESULTS: Chemical analysis by UPLC-QTOF-MS/MS identified 75 components in XKCP, among which 21 were prototype compounds absorbed into the bloodstream and 18 were metabolites. In HLP rats, XKCP significantly regulated serum lipid levels, ameliorated hepatic steatosis and damage, attenuated inflammatory and oxidative responses. Gut microbiota dysbiosis in HLP rats was also ameliorated by XKCP, the Firmicutes, Bacteroidetes and genera such as Clostridium, Bacteroidetes and Akkermansia myxophila being notably affected. Additionally, XKCP markedly reduced serum stearic acid and oleic acid concentrations while modulating key fatty acid biosynthetic and metabolic pathways. XKCP also increased the levels of beneficial SCFAs in the gut, such as hexanoic acid, isobutyric acid, isovaleric acid, valeric acid and 2-methylbutyric acid. Correlation analysis showed significant correlations between XKCP-induced changes in gut microbiota and metabolite profiles. Mechanistically, XKCP targeted the SCAP/SREBP-2 pathway to regulate cholesterol levels and sustain cholesterol homeostasis, thereby rectifying metabolic disorders. Consistent with the in vivo observations, XKCP and its potential active components (rosmarinic acid and chrysoeriol) significantly attenuated sodium oleate-induced HepG2 cells lipid accumulation. CONCLUSIONS: XKCP effectively mitigated HFD-induced hyperlipidemia. The underlying mechanism involves the improvement of gut microbiota balance, regulation of FFA and SCFAs levels and modulation of the SCAP/SREBP-2 pathway, collectively correcting metabolic disturbances. Rosmarinic acid and chrysoeriol were identified as the potential active components responsible for the anti-hyperlipidemic effects of XKCP. In summary, this study furnished experimental evidence and theoretical support for the potential clinical application of XKCP in HLP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasGastrointestinal MicrobiomeDrugs, Chinese HerbalLiverAnimalsMaleHumansRats, Sprague-DawleyDiet, High-FatRatsHomeostasisHep G2 Cells

Stichwörter der Autor:innen

FFAGut microbiotaHyperlipidemiaSCAP/SREBP-2SCFAsXia Ku Cao Paste

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China.
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China;; Hubei Shi-Zhen Laboratory, Wuhan, Hubei, 430065, China.
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China;; Hubei Shi-Zhen Laboratory, Wuhan, Hubei, 430065, China; Key Laboratory of Resource and Chinese Medicine Compounding, Ministry of Ed…
  • School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China; Hubei Shi-Zhen Laboratory, Wuhan, Hubei, 430065, China. Electronic address: lichunye@hbucm.edu.cn.
  • School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China; Hubei Shi-Zhen Laboratory, Wuhan, Hubei, 430065, China. Electronic address: newforest@163.com.
  • Hubei Shi-Zhen Laboratory, Wuhan, Hubei, 430065, China; Key Laboratory of Resource and Chinese Medicine Compounding, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, China. Electronic a…

Zitieren

APA

Du, Z., Wang, X., Xu, L., Hu, Z., Liu, M., Min, X., Hu, J., Meng, Y., Ye, L., Liu, S., & Shi, Z. (2026). Xia Ku Cao Paste restores intestinal microbiota homeostasis and improves hepatic metabolism disturbances to alleviate hyperlipidemia. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158010

Vancouver

Du Z, Wang X, Xu L, Hu Z, Liu M, Min X, et al. Xia Ku Cao Paste restores intestinal microbiota homeostasis and improves hepatic metabolism disturbances to alleviate hyperlipidemia. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158010

BibTeX
@article{Du2026,
  author = {Du, Zhonghua and Wang, Xiaole and Xu, Lei and Hu, Zhimei and Liu, Miaojing and Min, Xiaojuan and Hu, Junjie and Meng, Yan and Ye, Lichun and Liu, Songlin and Shi, Zhaohua},
  title = {Xia Ku Cao Paste restores intestinal microbiota homeostasis and improves hepatic metabolism disturbances to alleviate hyperlipidemia},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158010}
}
Kostenlos starten →